Support our call for opt-out testing of hepatitis B and hepatitis C in more emergency departments

January 19, 2023

The British Liver Trust has joined with other charities leading in the fight against Hepatitis B, Hepatitis C and HIV to call on the government to fund testing for blood-borne viruses in emergency departments across England.

In an open letter launched today, we’re asking that the Government’s successful opt-out testing programme is extended to all areas with a high prevalence of HIV – from Birmingham to Portsmouth, and Derby to Peterborough.

Routinely testing patients attending A & E has already identified more than 1,000 patients with viral hepatitis and HIV in London, Manchester, Brighton and Blackpool. This now needs to be rolled out to the rest of the UK.

Opt-out testing for these viruses will help the government meet its goal of eliminating Hepatitis C in England by 2025 and HIV transmissions by 2030. There are also approximately 440,000 people living with Hepatitis B in the UK but many remain unaware they have it. This testing will help reach more people in the community and find people who may avoid testing in other settings for fear of being stigmatised.

Early diagnosis not only saves and improves the lives of people living with these viruses but saves the NHS money. This is why we’re backing an open letter to the Public Health Minister and NHS England to extend opt-out testing to 40+ new hospitals in 32 areas.

Support this call by adding your name to the letter today.

More news

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

Potential for hundreds more liver transplants after NICE recommends new life-saving liver procedure for NHS use

The British Liver Trust welcomes the news that hundreds more liver transplants could be carried out after a new procedure that supplies a donor liver with oxygen before removal was approved by NICE for use in the NHS.   In-situ ...
New hope for people living with MASH as two treatments receive MHRA approval

New hope for people living with MASH as two treatments receive MHRA approval

People living with metabolic dysfunction-associated steatohepatitis (MASH) have received encouraging news, with the UK medicines regulator approving two treatments for the condition within the past month. The Medicines and Healthcare ...
New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

New Lancet Commission Highlights the Vital Role of Primary Care in Tackling Liver Disease

A major new Lancet Gastroenterology & Hepatology Commission, published today, has shone a spotlight on the crucial role that primary care can play in preventing, detecting and managing liver disease. We were proud to contribute to ...
No results found.
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.